762
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Post treatment and 3 month contrast enhanced MRI findings following HIFU of submucosal fibroids: a retrospective study

, , , &
Article: 2216897 | Received 14 Dec 2022, Accepted 17 May 2023, Published online: 25 May 2023

References

  • Vitale SG, Riemma G, Ciebiera M, et al. Hysteroscopic treatment of submucosal fibroids in perimenopausal women: when, why, and how? Climacteric. 2020;23(4):355–359.
  • Somigliana E, Reschini M, Bonanni V, et al. Fibroids and natural fertility: a systematic review and meta-analysis. Reprod Biomed Online. 2021;43(1):100–110.
  • Wei W, Yang W, Ting W, et al. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids. Eur Radiol. 2012;22(11):2553–2558.
  • Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.
  • Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196(2):184.e1–184–e6.
  • Kim YS, Kim TJ, Lim HK, et al. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids. Eur Radiol. 2017;27(9):3956–3965.
  • Funaki K, Fukunishi H, Funaki T, et al. Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol. 2007;14(5):616–621.
  • Milka M, Shiwa G, Florian R. Efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for uterine fibroids: an observational single-center study. Inter J Hyperthermia. 2021;38(2):30–38.
  • Youngsun K, Jeongwon L, Chehun C. Uterine fibroids: correlation of T2 signal intensity with semiquantitative perfusion MR parameters in patients screened for MR-guided High-Intensity focused ultrasound ablation. Radiology. 2016;278(3):925–935.
  • Liao P, Jiang J, Zeng YH, et al. Comparison of outcomes of hysteroscopic myomectomy of type 2 submucous fibroids greater than 4 cm in diameter via pretreatment with HIFU or GnRH-a. Int J Hyperthermia. 2021;38(1):183–188.
  • Yang W, Xin L, Wei W, et al. Long-term clinical outcomes of US-Guided High-Intensity focused ultrasound ablation for symptomatic submucosal fibroids: a retrospective comparison with uterus–sparing surgery. Acad Radiol. 2021;28(8):1102–1107.
  • Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single Centre. Eur Radiol. 2015;25(5):1317–1328.
  • Zhao WP, Chen JY, Chen WZ. Effect of biological characteristics of different type of uterine fibroids, as assessed with T2- weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2015;41(2):423–431.
  • Kim YS, Kim BG, Rhim H, et al. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation. Radiology. 2014;273(2):462–471.
  • Bai X, Lin Y, Chen Y, et al. The impact of FIGO type 3 fibroids on in-vitro fertilization outcomes: a nested retrospective case-control study. Eur J Obstet Gynecol Reprod Biol. 2020;247:176–180.
  • Duc NM, Keserci B. Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids. Diagn Interv Radiol. 2018;24(5):283–291.
  • Lenard ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–imaging predictors of success. Radiology. 2008;249(1):187–194.
  • Mashiach R, Inbar Y, Rabinovici J, et al. Outcome of magnetic resonance-Guided focused ultrasound surgery (MRgFUS) for FIGO class 1 fibroids. Eur J Obstet Gynecol Reprod Biol. 2018;221:119–122.
  • Yu L, Zhu S, Zhang H, et al. The efficacy and safety of MR-HIFU and US-HIFU in treating uterine fibroids with the volume <300 cm(3): a meta-analysis. Int J Hyperthermia. 2021;38(1):1126–1132.
  • Xie B, Zhang C, Xiong C, et al. High intensity focused ultrasound ablation for submucosal fibroids: a comparison between type I and type II. Int J Hyperthermia. 2015;31(6):593–599.
  • Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239.